{"schema_version":"secwatch.filing_event.v1","accession":"0000883984-25-000006","form_type":"8-K","ticker":"ICUI","cik":"0000883984","company_name":"ICU MEDICAL INC/DE","filed_at":"2025-02-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:06.669502+00:00","generated_at":"2026-05-26T02:56:08.789181+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"ICU Medical Q4 2024 revenue up 7% to $629.8M; adj. EPS $2.11 vs $1.57","bullets":["Revenue $629.8M (+7% YoY); GAAP gross margin improved to 36.1% from 29.2%.","GAAP net loss $(23.8)M ($(0.97)/share) vs $(17.1)M loss ($(0.71)) in Q4 2023.","Adjusted diluted EPS $2.11 vs $1.57 YoY; Adjusted EBITDA $105.5M vs $86.3M.","Company provided fiscal year 2025 guidance (detailed numbers not in excerpt)."],"urls":{"canonical":"https://secwatch.observer/filing/0000883984-25-000006","json":"https://secwatch.observer/filing/0000883984-25-000006.json","markdown":"https://secwatch.observer/filing/0000883984-25-000006.md","text":"https://secwatch.observer/filing/0000883984-25-000006.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/883984/000088398425000006/0000883984-25-000006-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/883984/000088398425000006/icui-20250227.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T02:56:08.789181+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}